TMDX Stock: Price, Earnings History and SEC Filings
TransMedics Group, Inc. (TMDX) last traded at $65.99, down 1.68% on the latest session and down 20.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.44 against an analyst estimate of $0.50, a miss of 12.0%.
$65.99 -1.68%
1 month-20.92%
52-week high$156.00
52-week low$60.11
Volume900,109
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TMDX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.44 | $0.50 | -12.00% |
| Mar 2026 | May 5, 2026 | $0.30 | $0.62 | -51.61% |
| Dec 2025 | Feb 24, 2026 | $0.57 | $0.41 | +39.02% |
| Sep 2025 | Oct 29, 2025 | $0.66 | $0.37 | +78.38% |
TMDX beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for TMDX
SEC filing data is not available right now. You can search for TMDX on SEC EDGAR.
TMDX news
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Oct 30, 2026 · finance.yahoo.com
- TransMedics to Present at Upcoming Investor ConferencesOct 29, 2026 · finance.yahoo.com
- TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026Oct 22, 2026 · finance.yahoo.com
About TransMedics Group, Inc.
TransMedics Group, Inc. (TMDX) is a US-listed public company on Nasdaq.